News
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...
Swap steaks for spinach and you might watch the scale plummet. In a 16-week crossover study, overweight adults who ditched ...
23h
Zacks Investment Research on MSNVKTX Initiates Phase 3 Study on Obesity Candidate VK2735Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results